Regenix Drugs Limited

Produces generic drugs, trades in bioscience products and medical equipment, and operates medical stores.

2007 | Chennai, Tamil Nadu (India) | Active
Last Updated:

Regenix Drugs Profile

Key Indicators

  • Authorised Capital ₹ 21.55 Cr
  • Paid Up Capital ₹ 18.08 Cr
  • Company Age 17 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 11.86 Cr
  • Satisfied Charges ₹ 17.81 Cr
  • Revenue Growth 9.70%
  • Profit Growth 0.30%
  • Ebitda -3.29%
  • Net Worth 17.22%
  • Total Assets 14.89%

About Regenix Drugs

Regenix Drugs Limited (RDL) is a leading Public Limited Indian Non-Government Company incorporated in India on 10 May 2007 and has a history of 17 years and ten months. Its registered office is in Chennai, Tamil Nadu, India.

The Corporate was formerly known as Regenix Drugs Private Limited. The Company is engaged in the Healthcare Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 21.55 Cr and a paid-up capital of Rs 18.08 Cr.

The company currently has active open charges totaling ₹11.86 Cr. The company has closed loans amounting to ₹17.81 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Regenix Drugs Limited India are Krishanamoorthy Nirosha as CFO and Srividhya as Company Secretary. Balaji Ramamurthy, Guhan Ramamurthy, Krishanamoorthy Nirosha, and Seven other members serve as directors at the Company.

Company Details

  • Location

    Chennai, Tamil Nadu, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24232TN2007PLC063446

  • Company No.

    063446

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    10 May 2007

  • Date of AGM

    22 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Chennai

Industry

Healthcare
Pharma

What products or services does Regenix Drugs Limited offer?

Regenix Drugs Limited offers a wide range of products and services, including Pathology Lab Equipments, Elisa Reader, Laboratory Equipment, Surgical & ICU Equipments, Stethoscope, Thermometers & Flowmeters, Industrial and Medical Infrared Thermometer, Analyzers & Analytical Instruments, Digital Analyzers, Anti Infective Drugs & Medicines.

Who are the key members and board of directors at Regenix Drugs?

Executive Team (3)

NameDesignationAppointment DateStatus
Krishanamoorthy Nirosha Country flag representing In CFO21-Jun-2021Current
Ramamurthy Ayyavuthevar Country flag representing In Managing Director30-Jun-2007Current
Srividhya Country flag representing In Company Secretary28-Sep-2016Current

Board Members (8)

NameDesignationAppointment DateStatus
Guhan Ramamurthy Country flag representing In Director 21-Jun-2021Current
Govindarajan Venkatakrishna Country flag representing In Director 20-Mar-2010Current
Akshay Arvind Country flag representing In Director 25-Sep-2022Current
Balaji Ramamurthy Country flag representing In Whole-Time Director 01-Oct-2022Current
Radhakrishnan Murali Country flag representing In Director 24-Sep-2023Current
Malathi Ramamurthy Country flag representing In Director 15-Apr-2012Current

Financial Performance of Regenix Drugs.

Regenix Drugs Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 9.7% increase. The company also saw a slight improvement in profitability, with a 0.3% increase in profit. The company's net worth Soared by an impressive increase of 17.22%.

Regenix Drugs revenue growth over time
Regenix Drugs profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
9.70%
Revenue from Operations
9.38%
Total Assets
14.89%
Profit or Loss
0.30%
Net Worth
17.22%
EBITDA
-3.29%

What is the Ownership and Shareholding Structure of Regenix Drugs?

In 2024, Regenix Drugs had a promoter holding of 62.97% and a public holding of 37.03%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹11.86 Cr

Satisfied Charges

₹17.81 Cr

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 11.71 Cr
  • Axis Bank Limited : 0.15 Cr

Latest Charge Details

DateLenderAmountStatus
10 Jan 2024Hdfc Bank Limited₹5.12 MOpen
05 Sep 2023Hdfc Bank Limited₹2.12 MOpen
13 Jul 2020Hdfc Bank Limited₹10.99 CrOpen
29 Jul 2015Axis Bank Limited₹1.47 MOpen
17 Jul 2017Others₹7.99 CrSatisfied

How Many Employees Work at Regenix Drugs?

Regenix Drugs has a workforce of 830 employees as of Mar 20, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Regenix Drugs Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Regenix Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Regenix Drugs's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Regenix Drugs

Recent activity within the organization

  • Charges

    A charge with Hdfc Bank Limited of Rs. 10.99 Cr registered on 13 Jul 2020 with Charge ID 100362965 was modified on 21 Jan 2025.

  • Annual General Meeting

    Regenix Drugs Limited last Annual general meeting of members was held on 22 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Regenix Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.51 Cr with Charge ID 100907370 was registered on 10 Jan 2024.

  • Director Appointment

    Radhakrishnan Venu Murali was appointed as a Director was appointed as a Director on 24 Sep 2023 & has been associated with this company since 1 year 6 months .

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.21 Cr with Charge ID 100786726 was registered on 05 Sep 2023.

Frequently asked questions

  • What is the Incorporation or founding date of Regenix Drugs Limited?

    Regenix Drugs Limited was incorporated on 10 May 2007.

  • What is authorized share capital and paid-up capital of Regenix Drugs Limited?

    The authorized share capital of Regenix Drugs Limited is ₹ 21.55 Cr and paid-up capital is ₹ 18.08 Cr.

  • Who are the current board members & directors of Regenix Drugs Limited?

    Currently 12 directors are associated with Regenix Drugs Limited.

    • Krishanamoorthy Nirosha
    • Balaji Ramamurthy
    • Guhan Ramamurthy
    • Krishanamoorthy Nirosha
    • Akshay Arvind
    • Radhakrishnan Venu Murali
    • Govindarajan Venkatakrishna
    • Malathi Ramamurthy
    • Gunasekaran Raju
    • Ramamurthy Ayyavuthevar
    • Ayyamperumal
    • Srividhya

  • What is the registered address of Regenix Drugs Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Regenix Drugs Limited is Jamal Sonu Terrace 42/1 Loganathan Nagar First Street 100 Feet Road, Choolaimedu India, Chennai, Tamil Nadu, 600094.

  • What is the corporate identification number (CIN) and company number of Regenix Drugs Limited?

    The corporate identification number (CIN) of Regenix Drugs Limited is U24232TN2007PLC063446 and the company number is 063446 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Regenix Drugs Limited?

    The Official website of Regenix Drugs Limited is https://www.regenix.in

  • What has been the recent revenue trend for Regenix Drugs Limited?

    According to the financial reports for the fiscal year 2024, the revenue trend for Regenix Drugs Limited has risen by 9.70%.

  • How many employees does Regenix Drugs Limited currently have?

    As Per 2024 financial reports, 830 employees are currently employed by Regenix Drugs Limited.

  • What change has been observed in the net worth of Regenix Drugs Limited, and by what percentage?

    The financial reports for the fiscal year 2024 indicates that The net worth of Regenix Drugs Limited has experienced an upsurge of 17.22%.

  • What are the total open charges for Regenix Drugs Limited?

    As per the financial statements for fiscal Year 2024, The total open charges for Regenix Drugs Limited amount to ₹ 11.86 Cr.

  • When was the last Balance Sheet of Regenix Drugs Limited filed with the ROC?

    The most recent Balance Sheet for Regenix Drugs Limited was filed with the ROC on 31 Mar 2024.

People also Viewed